IAPP and diabetes mellitus: In a previous study, these researchers identified a chemically modified derivative (MSL-7) of the novel autophagy enhancer MSL [4-(4-fluorophenyl)sulfonyl-5-methylthio-2-phenyloxazole] as a potential drug candidate for diabetes.7 Here, the group investigated whether the small molecule MSL-7 is able to increase autophagy, reduce IAPP oligomers, and improve glucose tolerance.